Is gABA B receptor a novel drug target for pancreatic cancer?
The data suggest the stimulation of GABA B R signaling as a novel target for the treatment and prevention of pancreatic cancer.
MMPs and TIMP-1 levels are elevated in SRF during RRD. A regression model consisting of MMP-3, MMP-8 and proMMP-9 may be proved to be of potential use in providing information for evaluation of the extent of RRD.